Literature DB >> 24290094

Diabetes and cancer: a 2013 synopsis.

M Buysschaert1, S Sadikot.   

Abstract

Diabetes, in particular type 2 diabetes, and cancer are two diseases that appear to be associated. Numerous epidemiological studies indicate indeed that diabetes increases the incidence of several tumors. Chronic hyperglycemia and/or insulin resistance with compensatory hyperinsulinemia could account for the association. On the other hand, the interpretation of the link between diabetes and cancer could be influenced by therapeutical interferences. Considering all these data together, cancer should be considered as a "new potential complication" of diabetes and integrated in the follow-up of diabetic subjects.
Copyright © 2013 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antihyperglycemic agents; Cancer; Diabetes; Hyperglycemia; Hyperinsulinemia

Mesh：

Substances：

Year:  2013        PMID： 24290094     DOI： 10.1016/j.dsx.2013.08.001

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN： 1871-4021


  12 in total

1.  A DASH dietary pattern and the risk of colorectal cancer in Canadian adults.

Authors:  E Jones-McLean; J Hu; L S Greene-Finestone; M de Groh
Journal:  Health Promot Chronic Dis Prev Can       Date:  2015-03       Impact factor: 3.240

2.  Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer.

Authors:  DeAnna Henderson; Danielle Frieson; Jeffrey Zuber; Solomon S Solomon
Journal:  Am J Med Sci       Date:  2017-05-19       Impact factor: 2.378

3.  Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population.

Authors:  Stefano Realdon; Alessandro Antonello; Diletta Arcidiacono; Elisa Dassie; Francesco Cavallin; Matteo Fassan; Maria Teresa Nardi; Alfredo Alberti; Massimo Rugge; Giorgio Battaglia
Journal:  Eur J Nutr       Date:  2015-07-10       Impact factor: 5.614

4.  On the status of β-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment.

Authors:  Lin-jie Lu; Lu Gan; Jin-bo Hu; Liang Ran; Qing-feng Cheng; Rui-jue Wang; Liang-bin Jin; Guo-sheng Ren; Hong-yuan Li; Kai-nan Wu; Ling-quan Kong
Journal:  Med Oncol       Date:  2014-04-12       Impact factor: 3.064

5.  Prediabetes and the risk of cancer: a meta-analysis.

Authors:  Yi Huang; Xiaoyan Cai; Miaozhen Qiu; Peisong Chen; Hongfeng Tang; Yunzhao Hu; Yuli Huang
Journal:  Diabetologia       Date:  2014-09-11       Impact factor: 10.122

Review 6.  Insulin analogs and cancer: a note of caution.

Authors:  Joseph A M J L Janssen; Aimee J Varewijck
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-26       Impact factor: 5.555

7.  Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.

Authors:  Harald Schrem; Valentin Schneider; Marlene Kurok; Alon Goldis; Maren Dreier; Alexander Kaltenborn; Wilfried Gwinner; Marc Barthold; Jan Liebeneiner; Markus Winny; Jürgen Klempnauer; Moritz Kleine
Journal:  PLoS One       Date:  2016-07-11       Impact factor: 3.240

Review 8.  Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia.

Authors:  T Grega; G Vojtechova; M Gregova; M Zavoral; S Suchanek
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

9.  On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test.

Authors:  Lin-jie Lu; Rui-jue Wang; Liang Ran; Lu Gan; Yang Bai; Liang-bin Jin; Zi-xiang Yao; Sheng-chun Liu; Guo-sheng Ren; Kai-nan Wu; Hong-yuan Li; Ling-quan Kong
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

10.  Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression.

Authors:  Wei Zhao; Xiaohui Zhang; Zhichao Zhou; Bei Sun; Wenyuan Gu; Jia Liu; Hong Zhang
Journal:  Mol Med Rep       Date:  2018-01-24       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.